Management of Severe Vomiting in First Trimester Pregnancy

Assessment and Severity Classification

• Use validated scoring tools such as the Pregnancy‑Unique Quantification of Emesis (PUQE) or the HyperEmesis Level Prediction (HELP) questionnaire to objectively classify vomiting severity in pregnant patients rather than relying solely on clinical impression. 1
• Do not rely on ketonuria as an indicator of dehydration severity, as it lacks reliability in this population. 1

First‑Line Antiemetic Therapy

• Initiate treatment with H1‑antihistamines, phenothiazines, or the combination of doxylamine + pyridoxine, which have the strongest safety and efficacy data for early‑pregnancy hyperemesis. These agents should not be withheld over teratogenicity concerns. 1

Second‑Line Antiemetic Options (When First‑Line Fails)

• Ondansetron can be used safely and effectively as a second‑line agent; although first‑trimester exposure carries a very small absolute increase in the risk of orofacial clefts, this risk is outweighed by the benefits of controlling severe vomiting. 1
• Metoclopramide is also safe and effective, either alone or in combination, but should be reserved for second‑line use because of the potential for extrapyramidal side effects. Administer intravenously as a slow bolus over at least 3 minutes. 1

Combination Antiemetic Therapy

• When a single antiemetic does not achieve adequate symptom control, combine agents with different mechanisms of action to maximize efficacy while monitoring for additive side‑effects. 1

Hydration Management

• Provide intravenous normal saline (0.9 % NaCl) with added potassium chloride in each bag, and adjust fluid composition based on daily electrolyte monitoring to correct dehydration and electrolyte losses associated with severe vomiting. 1

Critical Nutritional Supplementation

• Give thiamine (vitamin B1) to all pregnant patients admitted with vomiting or markedly reduced oral intake—either orally 100 mg three times daily or intravenously as part of a vitamin B complex (e.g., Pabrinex®). Thiamine must be administered before any dextrose‑containing fluids or parenteral nutrition to prevent Wernicke’s encephalopathy. 1

Safety and Adverse‑Reaction Precautions

• Always inquire about prior adverse reactions to antiemetic medications before prescribing. 1
• Discontinue any antiemetic promptly if an adverse reaction occurs. 1

Escalation and Treatment Limits

• Exhaust all pharmacologic, hydration, and nutritional strategies—including combination therapy and, if needed, nasogastric or parenteral nutrition—before considering termination of pregnancy as a therapeutic option. 1